1 | Figueiredo M ET AL | JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B: APPLIED BIOMATERIALS (2009)
University of Coimbra, Portugal

2 | Nannmark u et al | CLINICAL IMPLANT DENTISTRY AND RELATED RESEARCH (2008)
University of Göteborg, Sweden

 

Nature provides all the necessary elements for bone regeneration

TECNOSS® BONE MATRIX: A DUAL PHASE REVOLUTION
Tecnoss® Bone Matrix granules are endowed with characteristics very similar to human mineral bone1, and can be used as an alternative to autologous bone.
Their natural micro-porous consistency facilitates new bone tissue formation in defect sites and accelerates the regeneration process.
Gradually resorbable, it preserves the original graft shape and volume (osteoconductive property)2.

Research and development of biomaterials have gone through many stages, but always toward one goal: to heal bone deficit with newly-formed quality tissue in order to achieve functional recovery.
All of this in the least time possible.
The examination of clinical results and the commercial diffusion of various kinds of products developed by the biomedical industry show a clear superiority of products of natural origin over those of synthetic derivation.
The structure of animal bone is morphologically more similar to human bone than any synthesized product.
Over the last twenty years several processes have been developed to allow the grafting of heterologous origin products in the human body without adverse reaction.
The first products developed through these technologies have shown encouraging clinical results, even if made of bone mineral matrix only.
The Tecnoss® new generation of biomaterials, thanks to a revolutionary technology, goes beyond the simple role of aiding natural bone regrowth by stimulating and accelerating this vital physiological process.

Our aim is to accelerate and guide the natural bone regeneration process
Tecnoss® developed and patented a unique biotechnology that prevents the ceramization phase of natural bone and preserves the tissue collagen, allowing an osteoclastic-type remodelling of the biomaterial, similar to physiological bone turnover

SEM image of a Tecnoss® Gen-Os granule: vascular canal entrance with evident centralized osteonic structure Courtesy of Dr Ulf Nannmark, Göteborg University, Sweden

SEM image of a Tecnoss® Gen-Os granule colonized by osteoblasts from a cell-line (MG63) Courtesy of Dr Ulf Nannmark, Göteborg University, Sweden

 

 

 

 

 

 

 
 
  Tecnoss s.r.l.- C.F. e P.I.: 07524260010
Registered office: Via Morghen 34 10100 Torino – Italy - Head office: Piazza Papa Giovanni XXIII 2 10094 Giaveno (TO) – Italy - Production site: Via Monte Nero 13 10050 Coazze (TO) – Italy
Registro Imprese del Tribunale di Torino n° 07524260010 Rea n° TO-902205- Capitale sociale: 80.000,00 Euro interamente versato
Phone: +39 011 9377347 - Fax: +39 011 9363262 - info@tecnoss.com